According to Kings Research, the global protein sequencing market size was valued at USD 1,231.5 million in 2023 and is projected to grow from USD 1,279.9 million in 2024 to USD 1,743.8 million by 2031, exhibiting a CAGR of 4.52% during the forecast period. The market is witnessing steady growth due to the increasing demand for advanced protein characterization technologies across biopharmaceutical research, drug discovery, proteomics, biotechnology, and academic research. Protein sequencing plays a critical role in identifying the amino acid sequence of proteins, understanding protein structure and function, detecting modifications, and supporting the development and quality control of biologics and therapeutic products.
Get the Full Detailed Insights Report: https://www.kingsresearch.com/protein-sequencing-market-1631
Protein Sequencing Market Overview
Protein sequencing is an essential analytical process used to determine the precise amino acid sequence of proteins and peptides. It enables researchers to understand protein structure, biological activity, interactions, and post-translational modifications. The technology has become increasingly important in proteomics, pharmaceutical research, biotechnology, and clinical research, where detailed protein characterization is required to support drug development and biological investigations.
The expansion of the global biopharmaceutical industry is one of the major factors supporting the growth of the protein sequencing market. Biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and other protein-based therapeutics, require comprehensive characterization throughout the research, development, manufacturing, and quality-control stages. Protein sequencing technologies provide researchers with detailed information that can help verify protein identity, detect sequence variations, and ensure product consistency.
Technological developments in mass spectrometry and other analytical techniques are also transforming the protein sequencing landscape. Modern instruments provide greater sensitivity, accuracy, and throughput, allowing researchers to analyze increasingly complex protein samples. Improvements in automation, software, data analysis, and sample preparation are further supporting the adoption of protein sequencing solutions.
Key Highlights of the Protein Sequencing Market
- The global protein sequencing market is projected to reach USD 1,743.8 million by 2031.
- The market is expected to register a CAGR of 4.52% from 2024 to 2031.
- Mass spectrometry remains a key technology for protein sequencing due to its accuracy, sensitivity, and versatility.
- Growing biopharmaceutical research is increasing demand for advanced protein characterization solutions.
- Rising investments in proteomics and life sciences research are creating opportunities for market expansion.
- Software and analytical services are gaining importance as protein sequencing generates increasingly complex datasets.
- North America is expected to remain an important market due to strong biotechnology and pharmaceutical research infrastructure.
Growing Demand for Protein Characterization
The increasing complexity of biological molecules has created a strong need for accurate protein characterization. Proteins can undergo structural changes and post-translational modifications that influence their biological functions. Consequently, researchers require sophisticated analytical techniques to identify and characterize proteins with a high degree of accuracy.
Protein sequencing provides valuable information for studying protein identity, sequence variations, structural characteristics, and biological activity. In pharmaceutical development, these capabilities are particularly important for characterizing therapeutic proteins and ensuring that products meet established quality requirements.
The growing adoption of personalized medicine is another factor supporting demand for advanced protein analysis. As researchers move toward more targeted approaches to disease diagnosis and treatment, understanding molecular-level changes becomes increasingly important. Protein sequencing and related proteomics technologies can help researchers investigate biomarkers and molecular pathways associated with diseases.
Technological Advancements Driving Market Growth
Technological innovation is one of the most significant factors shaping the protein sequencing market. Traditional sequencing techniques such as Edman degradation continue to have applications in specific research settings; however, mass spectrometry has emerged as a highly valuable approach because of its ability to analyze complex samples and provide detailed molecular information.
Mass spectrometry-based sequencing enables researchers to analyze proteins and peptides based on their mass-to-charge ratios and fragmentation patterns. Continuous improvements in instrument resolution, sensitivity, speed, and automation have expanded the applications of this technology.
Hybrid approaches are also gaining attention because they combine complementary analytical techniques to improve sequencing accuracy and provide more comprehensive protein characterization. These approaches can be particularly useful when researchers need to investigate complex proteins, modified peptides, or challenging biological samples.
In addition, advancements in bioinformatics and computational analysis are helping researchers process and interpret large volumes of sequencing data. The integration of software solutions with laboratory instruments allows users to streamline workflows, identify protein sequences, and analyze complex datasets more efficiently.
Impact of Biopharmaceutical Research
The rapid growth of the biopharmaceutical sector represents a major opportunity for the protein sequencing market. Protein-based therapeutics require extensive characterization to verify their identity, purity, structure, and consistency. Protein sequencing technologies are therefore used across multiple stages of biologic development.
During early-stage research, sequencing helps scientists understand candidate proteins and investigate their biological properties. During development and manufacturing, sequencing can support quality assessment and characterization. The growing pipeline of biologics and biosimilars is consequently expected to increase the requirement for reliable protein analysis technologies.
The expansion of biosimilar development is particularly relevant. Biosimilars require detailed analytical characterization to demonstrate similarity to reference biologic products. Protein sequencing and mass spectrometry can provide valuable information for comparing protein sequences and identifying potential differences.
Market Segmentation Analysis
By Product & Service
Based on product & service, the protein sequencing market is segmented into instruments, reagents & consumables, software, and services.
The instruments segment represents a significant component of the market, supported by the increasing adoption of advanced analytical systems in pharmaceutical companies, biotechnology organizations, and research institutions. Modern sequencing instruments are designed to provide high sensitivity, accuracy, automation, and reproducibility.
The reagents & consumables segment is expected to benefit from the recurring requirement for laboratory supplies. Protein sequencing workflows require various reagents, sample-preparation materials, columns, chemicals, and other consumables, creating a continuous source of demand.
The software segment is becoming increasingly important as sequencing workflows generate large datasets that require specialized computational tools. Advanced software helps researchers interpret sequencing results, identify proteins, manage experimental data, and improve workflow efficiency.
The services segment is also expanding as organizations increasingly outsource specialized analytical activities to laboratories and contract research organizations. Outsourcing enables smaller biotechnology companies and research groups to access advanced sequencing capabilities without making significant investments in infrastructure and specialized personnel.
By Technology
Based on technology, the market is categorized into mass spectrometry, Edman degradation, and hybrid approaches.
Mass spectrometry is a major technology segment due to its ability to deliver detailed and highly sensitive molecular analysis. It is widely used in proteomics and biopharmaceutical research and can support the analysis of complex protein samples.
Edman degradation is a conventional protein sequencing technique that identifies amino acids sequentially from the N-terminus of a protein or peptide. Although newer technologies have gained substantial adoption, Edman degradation remains relevant for specific applications involving purified proteins and peptides.
Hybrid approaches combine multiple analytical techniques to overcome the limitations associated with individual methods. These approaches can provide complementary information and improve sequencing confidence, particularly for complex biological samples.
By Application
Based on application, the market is segmented into biopharmaceuticals and academic & research institutes.
The biopharmaceuticals segment is expected to remain a major contributor to market growth. Increasing development of biologics, biosimilars, therapeutic proteins, and other protein-based products is creating a strong requirement for accurate protein characterization.
Pharmaceutical and biotechnology companies use sequencing technologies for research, development, quality assessment, and characterization. The increasing regulatory emphasis on product consistency and analytical characterization is further encouraging the use of advanced protein analysis technologies.
The academic & research institutes segment is supported by increasing investments in proteomics, molecular biology, genomics, and life sciences research. Universities and research organizations use protein sequencing to investigate disease mechanisms, protein interactions, biomarkers, and cellular processes.
Regional Analysis
North America
North America is expected to maintain a significant position in the global protein sequencing market. The region benefits from a well-established pharmaceutical and biotechnology ecosystem, substantial research investments, advanced laboratory infrastructure, and strong adoption of analytical technologies.
The presence of major pharmaceutical companies, biotechnology firms, research institutions, and technology providers supports the development and adoption of protein sequencing solutions. Increasing investment in biologics, precision medicine, and proteomics research is expected to further strengthen regional demand.
Europe
Europe represents another important market for protein sequencing technologies. The region has a strong life sciences research base and a well-developed pharmaceutical sector. Increasing research into biologics, biosimilars, personalized medicine, and molecular diagnostics is supporting demand for protein characterization.
Government and private-sector investments in biotechnology and scientific research are also contributing to market development. As pharmaceutical companies continue to improve their biologic development and analytical capabilities, demand for sequencing instruments, reagents, software, and services is expected to increase.
Asia-Pacific
Asia-Pacific is expected to offer significant growth opportunities during the forecast period. Countries across the region are expanding their pharmaceutical and biotechnology industries while increasing investments in research and development.
The growing manufacturing of biologics, increasing healthcare expenditure, expansion of research institutions, and rising adoption of advanced laboratory technologies are supporting the regional protein sequencing market. China, Japan, South Korea, and India are among the countries contributing to the development of the region's life sciences ecosystem.
The expansion of contract research and manufacturing services is also creating opportunities for protein sequencing service providers.
Latin America and Middle East & Africa
Latin America and the Middle East & Africa are expected to experience gradual market development as investments in healthcare infrastructure, biotechnology, and research increase. Growing awareness of advanced analytical technologies and the expansion of pharmaceutical research activities are expected to create additional opportunities.
However, factors such as high equipment costs, limited access to specialized infrastructure, and shortages of skilled professionals may continue to affect adoption in certain countries.
Competitive Landscape
The protein sequencing market is characterized by the presence of technology providers offering analytical instruments, reagents, consumables, software, and specialized services. Companies are focusing on technological innovation, product launches, strategic partnerships, research collaborations, and acquisitions to strengthen their market positions.
Leading players operating in the broader protein analysis and sequencing ecosystem include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Waters Corporation, Bruker Corporation, SCIEX, Shimadzu Corporation, and Merck, among others.
Companies are increasingly focusing on improving instrument sensitivity, automation, workflow integration, and data-analysis capabilities. The development of user-friendly software and integrated laboratory solutions is also becoming an important competitive strategy.
Strategic collaborations between technology providers, pharmaceutical companies, academic institutions, and research organizations are expected to contribute to innovation within the industry. Such partnerships can accelerate the development of new analytical workflows and expand the application of protein sequencing technologies.
Add comment